Type III interferons disrupt the lung epithelial barrier upon viral recognition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Authors
Keywords
-
Journal
SCIENCE
Volume -, Issue -, Pages eabc3545
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-06-12
DOI
10.1126/science.abc3545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- COVID-19 and emerging viral infections: The case for interferon lambda
- (2020) Ludmila Prokunina-Olsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Middle East respiratory syndrome
- (2020) Ziad A Memish et al. LANCET
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
- (2020) Guqin Zhang et al. JOURNAL OF CLINICAL VIROLOGY
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Interferon Lambda Inhibits Bacterial Uptake During Influenza Super-Infection
- (2019) Helen E. Rich et al. INFECTION AND IMMUNITY
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
- (2019) Achille Broggi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection
- (2017) Charlotte Odendall et al. JOURNAL OF IMMUNOLOGY
- Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo
- (2017) Florian Douam et al. mBio
- Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection
- (2016) Paul J. Planet et al. mBio
- IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
- (2015) Katrina Blazek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
- (2015) Helen M. Lazear et al. Science Translational Medicine
- The co-pathogenesis of influenza viruses with bacteria in the lung
- (2014) Jonathan A. McCullers NATURE REVIEWS MICROBIOLOGY
- Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection
- (2013) A. M. Jamieson et al. SCIENCE
- Disease Tolerance as a Defense Strategy
- (2012) R. Medzhitov et al. SCIENCE
- SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
- (2010) Matthew B. Frieman et al. PLoS Pathogens
- Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
- (2009) Eun-Woo Lee et al. EMBO JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now